Can SUVmax values of Ga-68-PSMA PET/CT scan predict the clinically significant prostate cancer?

被引:113
作者
Demirci, Emre [1 ]
Kabasakal, Levent [2 ]
Sahin, Onur E. [2 ]
Akgun, Elife [2 ]
Gultekin, Mehmet Hamza [3 ]
Doganca, Tunkut [4 ]
Tuna, Mustafa B. [5 ]
Obek, Can [4 ]
Kilic, Mert [6 ]
Esen, Tarik [7 ]
Kural, Ali R. [8 ]
机构
[1] Yeditepe Univ, Fac Med, Dept Nucl Med, Istanbul, Turkey
[2] Istanbul Univ, Cerrahpasa Med Fac, Dept Nucl Med, Istanbul, Turkey
[3] Istanbul Univ, Cerrahpasa Med Fac, Dept Urol, Istanbul, Turkey
[4] Taksim Hosp, Acibadem Hlth Grp, Dept Urol Uroonkol, Istanbul, Turkey
[5] Maslak Hosp, Acibadem Hlth Grp, Dept Urol, Istanbul, Turkey
[6] VKV Amer Hosp, Dept Urol, Istanbul, Turkey
[7] Koc Univ, Fac Med, Dept Urol, Istanbul, Turkey
[8] Acibadem Univ, Fac Med, Dept Urol, Istanbul, Turkey
关键词
Gallium-68; Gleason scoring system; guided prostate biopsy; prostate cancer; Prostate Cancer Grading System; prostate-specific membrane antigen; Positron emission tomography/computed tomography; ACTIVE SURVEILLANCE; GLEASON SCORE; REPEAT BIOPSY; PSMA; EXPRESSION; DIAGNOSIS; ACCURACY; MEN; PSA;
D O I
10.1097/MNM.0000000000000942
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose The intensity of prostate-specific membrane antigen (PSMA) expression increases as the tumor grade increases and the uptake of Ga-68-PSMA is higher in high-grade tumors. The aim of the present study was to evaluate the correlation of preoperative tracer uptake of primary tumor to Gleason Score in patients who underwent prostatectomy. Patients and methods We retrospectively evaluated 141 patients who had Ga-68-PSMA positron emission tomography/computed tomography (PET/CT) imaging and who underwent prostatectomy. All patients had a diagnosis of prostate cancer on the basis of 10-24 cores transrectal ultrasound-guided biopsy (TRUS-Bx). Histological assessment was performed according to the New Contemporary Prostate Cancer Grading System. All patients had a prostate-specific antigen (PSA) level measurement within maximum of 28 days before Ga-68-PSMA PET/CT. Region of interests were drawn manually around the prostate gland, avoiding the bladder activity, to calculate the maximum standardized uptake values (SUVmax) values. Results The median PSA values for all patients were 10.0 ng/ml. PSA values for low-risk patients were significantly lower than those of high-risk patients (P<0.001). There were 41.1% upgrades and 7.8% downgrades following prostatectomy in terms of Grade Groups. According to the final pathology reports, 21% (n=16) of patients moved from a low-risk level (grade groups 1+2) to a high-risk level (grade groups 3+4+5). The median SUVmax value was 8.8, ranging from 2.1 to 62.4. There was a strong correlation between SUVmax values and grade groups (Pearson rho=0.66) (P<0.001). The mean SUVmax values of high-risk patients were significantly higher than those of low-risk patients (18.9 +/- 12.1 vs. 7.16 +/- 6.2, respectively) (P<0.001). Receiver operation characteristic curve analysis of SUVmax at the cut-off value of 9.1 showed a high sensitivity (78%) and specificity (81%) for detection of high risk disease. Conclusion SUVmax values correlate significantly with the grade groups of the primary tumor. The intraprostatic accumulation sites may predict clinically significant cancer and potentially serve as a target for biopsy sampling in conjunction with mpMRI in selected patients.
引用
收藏
页码:86 / 91
页数:6
相关论文
共 26 条
[1]   PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions [J].
Afshar-Oromieh, A. ;
Malcher, A. ;
Eder, M. ;
Eisenhut, M. ;
Linhart, H. G. ;
Hadaschik, B. A. ;
Holland-Letz, T. ;
Giesel, F. L. ;
Kratochwil, C. ;
Haufe, S. ;
Haberkorn, U. ;
Zechmann, C. M. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (04) :486-495
[2]   Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients (vol 44, pg 1258, 2017) [J].
Afshar-Oromieh, Ali ;
Holland-Letz, Tim ;
Giesel, Frederik L. ;
Kratochwil, Clemens ;
Mier, Walter ;
Haufe, Sabine ;
Debus, Nils ;
Eder, Matthias ;
Eisenhut, Michael ;
Schaefer, Martin ;
Neels, Oliver ;
Hohenfellner, Markus ;
Kopka, Klaus ;
Kauczor, Hans-Ulrich ;
Debus, Juergen ;
Haberkorn, Uwe .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (10) :1781-1781
[3]   Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer [J].
Barinka, C. ;
Rojas, C. ;
Slusher, B. ;
Pomper, M. .
CURRENT MEDICINAL CHEMISTRY, 2012, 19 (06) :856-870
[4]   Identifying Candidates for Active Surveillance: An Evaluation of the Repeat Biopsy Strategy for Men with Favorable Risk Prostate Cancer [J].
Barzell, Winston E. ;
Melamed, Myron R. ;
Cathcart, Paul ;
Moore, Caroline M. ;
Ahmed, Hashim U. ;
Emberton, Mark .
JOURNAL OF UROLOGY, 2012, 188 (03) :762-767
[5]   Pathological Upgrading and Up Staging With Immediate Repeat Biopsy in Patients Eligible for Active Surveillance [J].
Berglund, Ryan K. ;
Masterson, Timothy A. ;
Vora, Kinjal C. ;
Eggener, Scott E. ;
Eastham, James A. ;
Guillonneau, Bertrand D. .
JOURNAL OF UROLOGY, 2008, 180 (05) :1964-1967
[6]   The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume [J].
Corcoran, Niall M. ;
Casey, Rowan G. ;
Hong, Matthew K. H. ;
Pedersen, John ;
Connolly, Stephen ;
Peters, Justin ;
Harewood, Laurence ;
Gleave, Martin E. ;
Costello, Anthony J. ;
Hovens, Chris M. ;
Goldenberg, S. Larry .
BJU INTERNATIONAL, 2012, 110 (01) :36-42
[7]   Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging [J].
Demirci, Emre ;
Sahin, Onur Erdem ;
Ocak, Meltem ;
Akovali, Burak ;
Nematyazar, Jamal ;
Kabasakal, Levent .
NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (11) :1169-1179
[8]   Preclinical evaluation of a bispecific low-molecular heterodimer targeting both PSMA and GRPR for improved PET imaging and therapy of prostate cancer [J].
Eder, Matthias ;
Schaefer, Martin ;
Bauder-Wuest, Ulrike ;
Haberkorn, Uwe ;
Eisenhut, Michael ;
Kopka, Klaus .
PROSTATE, 2014, 74 (06) :659-668
[9]   The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Definition of Grading Patterns and Proposal for a New Grading System [J].
Epstein, Jonathan I. ;
Egevad, Lars ;
Amin, Mahul B. ;
Delahunt, Brett ;
Srigley, John R. ;
Humphrey, Peter A. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (02) :244-252
[10]   Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature [J].
Futterer, Jurgen J. ;
Briganti, Alberto ;
De Visschere, Pieter ;
Emberton, Mark ;
Giannarini, Gianluca ;
Kirkham, Alex ;
Taneja, Samir S. ;
Thoeny, Harriet ;
Villeirs, Geert ;
Villers, Arnauld .
EUROPEAN UROLOGY, 2015, 68 (06) :1045-1053